LeMaitre Vascular, Inc. (LMAT)

NASDAQ • Healthcare

$78.95

-$1.23 (-1.5%)

Market closed

Last close at October 2, 2026 at 20:00 UTC

Open$81.36

Day Range$78.66 - $81.36

Avg. Volume (3M)268.2K

Market Cap$1.8B

P/E Ratio27.2

52 Week Range

$78.22$118.01

Next EarningsIn 32 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$70.3M100%

Gross Profitminus cost of goods$50.7M72%

Operating Incomeminus R&D and overhead$20.3M29%

Net Incomeminus taxes and the rest$17M24%

In plain terms: out of every $100 in revenue, LeMaitre Vascular, Inc. keeps $24 as net profit.

Fundamentals & Financials

Revenue (TTM)

$262.4M

Net Income (TTM)

$65.6M

EPS (TTM)

$2.9

ROA (TTM)

10.25%

Current Ratio

16.31

Dividend Yield

0.26%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+5.3%Q3 2025$0.6

+9.9%Q4 2025$0.62

+1.5%Q1 2026$0.68

+3.0%Q2 2026$0.68

-8.3%Q3 2026$0.74

Nov 5

in 32 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -8.3%

LeMaitre Vascular trailed consensus on both revenue and EPS in the second fiscal quarter of 2026, reported Aug. 4, as revenue of $70.4 million trailed the $71.5 million estimate, -1.5%, and EPS of $0.74 trailed the $0.81 estimate, -8%. Revenue rose 9.6% year over year to about $70.4 million, while gross profit of about $50.8 million left gross margin near 72% and operating income of about $20.4 million left operating margin around 29%. Net income increased 23.7% to about $17.1 million from $13.8 million a year ago, and EPS of $0.74 was up 23.3% from $0.60. Operating cash flow came in at about $16.0 million, the company repurchased about $112,000 of stock, and it paid about $5.7 million in dividends. Next-period consensus calls for EPS of $0.69 on revenue of $67.4 million.

View full earnings history

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. (NASDAQ: LMAT) develops, distributes, and maintains medical devices and implants used to treat peripheral vascular disease. The healthcare company sells surgical tools and vascular products worldwide through its own sales force and distributors, and it generated $249.6 million of revenue in FY2025.

Name

LeMaitre Vascular, Inc.

CEO

George W. LeMaitre

Website

www.lemaitre.com

Industry

Healthcare

Year Founded

1983

Employees

651

Today's Snapshot

AI-generated

LMAT closed 1.5% lower at 78.96, while its sector was flat. The day ended with LMAT within 0.9% of its 52-week low of 78.22.

Trading Volume

Above 10d avg 256.7K

309.4K

vs S&P 500 Today

Underperforming Market

-2.31%

Updated: October 2, 2026 at 20:21 UTC

Technical Indicators

0 Buy3 Neutral5 Sell

LMAT is positioned below most moving averages, including a much higher 200-day average, keeping the broader bias bearish while ADX near 18 suggests the trend lacks conviction. Momentum is mixed—RSI in the high 30s and a mildly negative MACD point to limited downside momentum, while short-term oscillators show occasional buying attempts. Volume information is unfavorable with a negative OBV, and volatility is contained with an ATR around $2.1. Technical takeaway: Sell — price remains under key averages with weak trend confirmation and subdued volatility.

All signals